sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÄêËêÏà¹ØÐԻư߱äÐÔ
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ÄêËêÏà¹ØÐԻư߱äÐÔ

ǰÑÔ

ÄêËêÏà¹ØÐԻư߱äÐÔ(age related macular dege­neralion, AMD)ÊÇ65ËêÒÔÉÏÍíÄêÈËÖÂäµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ¡£AMD·ÖΪÎÞÐÂÉúѪ¹ÜÌìÉúµÄ¸ÉÐÔÒÔ¼°ÐÂÉúѪ¹ÜÌìÉúµÄʪÐÔÌåÏÖ¡£ÊªÐÔAMD»¼Õß±¬·¢CNVÊǵ¼ÖÂÊÓÁ¦ËðʧµÄ×î³£¼ûÒòËØ¡£±¾Õ½«ÏÈÈÝCNVµÄÔìÄ£ÒªÁì¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó¡¢¼ÒÍá¢â¨ºï

¡¾ÔìÄ£»úÖÆ¡¿£º

¼¤¹âÓÕµ¼CNVÄ£×ÓÊdz£¼ûµÄÒªÁì¡£1979Äê £¬RyanµÈÊ״νÓÄɸ߹¦Âʼ¤¹â´©Í¸BruchĤ֯×÷³öCNV¶¯ÎïÄ£×Ó¡£1989Äê £¬DobiÆ·¼¶Ò»´ÎÓ¦ÓÃ647nm²¨³¤¡¢120mWµÄë´¼¤¹â¿ÉÔì³ÉCNVÄ£×Ó¡£1998Äê £¬TobeµÈ½«ë´¼¤¹â¹âÄýÊõÓ¦ÓÃÓÚÖÆ×÷СÊóCNVÄ£×Ó £¬ÒԺ󼤹âÓÕµ¼CNVÄ£×Ó±»ÆÕ±éÓ¦ÓÃÓÚ»ù´¡ÊµÑéºÍÖÎÁÆÒªÁìµÄÑо¿ÖС£À¶ÂÌë²¼¤¹â´©Í¸Á¦½ÏÈõ £¬Ö÷Òª×÷ÓÃÓÚÊÓÍøÄ¤ÄÚ²ãºÍRPE²ã¡£ë´¼¤¹âÖ÷Òª×÷ÓÃÓÚRPEºÍÂöÂçĤÄڲ㡣¼¤¹âÓÕµ¼CNVÄ£×ÓµÄÓŵãÔÚÓÚÓëÈËÀàCNV¼²²¡±¬·¢×ÔÈ»Àú³ÌÏàËÆ £¬µ«²î±ðÑо¿CNVÄ£×ÓÀÖ³ÉÂʲî±ð £¬Óë²î±ðʵÑé½ÓÄɶ¯ÎïÀàÐÍ¡¢¼¤¹âÖÖÀ༰¶ÔÊÓ²ìÕï¶ÏCNVµÄ±ê×¼·×ÆçÓйØ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

1.СÊó Ë«ÑÛµÎÓø´·½ÍÐßÁ¿¨°·µÎÑÛҺɢͫ £¬¸¹Ç»×¢Éä1£¥Îì°Í±ÈÍ×ÄÆ(10ml/kg)Âé×íСÊó £¬ÊµÑéÑÛµÎÓÃÒ½ÓÃ͸Ã÷ÖÊËáÄÆÄý½º £¬ÑÛǰ°²ÅÅ2cm×2cm¸Ç²£Æ¬ £¬¾­ÁÑ϶µÆÓÃ532nm¼¤¹â¹¦ÂÊ200mW £¬¹â°ßÖ±¾¶100m £¬ÆØ¹âʱ¼ä100ºÁÃë £¬¾àÊÓÈéÍ·1.5-2.0PI×óÓÒλÖÃÒÔÊÓÈéͷΪÖÐÐľÙÐйâÄý £¬ÆäÖÐÐÐCNVÄ£×ÓÅжϺÍÃâÒßÓ«¹âȾɫ×éСÊó¹âÄý4~6µã£¯ÑÛ£»¹âÄýºóÓÐÆøÅݱ¬·¢±ê¼Ç»÷ÆÆBruchĤ £¬ ¼ÇΪÓÐÓõã¡£

2.¼ÒÍà ÍÃÑÛ¼¤¹âÓÕµ¼Ä£×ÓÔÚº£ÄÚÓ¦ÓýÏΪÆÕ±é £¬ÓŵãÔÚÓÚÍÃÑÛ½ÏÖ®ÊóÑÛ´ó £¬Ò×ÓÚÄ£×ÓʵÑé²Ù×÷Óë¼ì²é¡£Ë«ÑÛɢͫ £¬ÑÛ±íµÎÈëÍâòÂé×í¡£Ã¿Ö»ÑÛÔÚÈ«ÊÓÍøÄ¤¾µÏÂÓÃë´¼¤¹â £¬²¨³¤647nm £¬¹¦ÂÊ700~800mW £¬¹â°ßÖ±¾¶50µm £¬¼¤¹â¹¦ÂÊÆØ¹âʱ¼ä0.05Ãë £¬ÔÚÊÓÈéÍ·¼°ËèÏßÏ·½¹âÄý20¸öµã £¬¹â°ß¾àÀë300µm¡£

3.â¨ºï ºïµÄÊÓÍøÄ¤¼°»Æ°ß½á¹¹ÓëÈËÀàÏàËÆ £¬ÑÛÇò¾Þϸ±ãÓÚ²Ù×÷ £¬¾ßÓÐÓ«¹âÉøÂ©µÄÌØµã £¬ÊÇÓÃÓÚÁÙ´²Ò©ÎïɸѡµÄÊ×ѡģ×Ó¡£RyanµÈʹÓÃë²¼¤¹â £¬¹¦ÂÊ200~950mW £¬¹â°ßÖ±¾¶50~200µm £¬ÆØ¹âʱ¼ä0.1~0.5Ãë¡£

¡¾Ä£×ÓÌØµã¡¿£º

1.СÊó ³£½ÓÄÉÃâÒß×黯ÊÖÒÕÓ¦ÓÃCD31±ê¼ÇÄÚÆ¤Ï¸°û £¬ÔÚ¹âÒɺó14ÌìʱCNVÄ£×ÓÊóµÄÊÓÍøÄ¤¹â¼¤²¿Î»¿É¼ûÏÔ×ŵÄÂÌɫӫ¹âÍÅ¿é £¬Åú×¢ÐÂÉúѪ¹ÜÐγÉ £¬´Ó¶øÌåÏÖCNVÄ£×ÓÓÕµ¼Àֳɡ£

2.¼ÒÍà ¼¤¹â°ß·ºÆðǿӫ¹âÉøÂ©ÎªCNVÐγÉ £¬µÚ3~4ÖܼûÎȹ̵ÄÉøÂ©¹â°ß £¬CNV±¬·¢ÂÊ66.7£¥ £¬ÉøÂ©ÂÊ51.7£¥¡£¹âÄýºó3Ìì¼´ÓÐÉÙÁ¿¹â°ß·ºÆðÓ«¹âÉøÓ¿ £¬²¢Öð½¥Ôö¶à £¬21Ìì´ïá¯Áë £¬²¢Ò»Á¬µ½¹âÄýºó56Ìì¡£OCTÏÔʾÔìÄ£ºó7ÌìÉÙÁ¿¹â°ß²¿Î»É«ËØÉÏÆ¤²ã·´ÉäÖÐÖ¹ £¬ÆäÏ·½¾ÖÔîÐÔ¸ßÃܶȺì°×É«·´ÉäÇø³ÊÍÅ¿é×´¡¢ËóÐλò²»¹æÔòÐÎ £¬±ßÑØÎªñ£ºÛÐγɵIJ»¹æÔòÇ¿·´ÉäÇø £¬CNV·ºÆð£»Ö®ºóCNVÖð½¥Ôö¶à £¬ÖÁ21Ìì¸÷×é´ï×î¶à£»ÍíÆÚ²¿·ÖCNVñ£ºÛ»¯¡£Ó«¹âÉøÂ©µÄÅÌËã[£¨Ó«¹âÉøÂ©±¬·¢ÂÊ£½·ºÆðÓ«¹âÉøÂ©µÄ¼¤¹âµãÊý£¯ËùÊÓ²ìµÄ¼¤¹âµãÊý£©×100£¥]¡£

3.ºï ¹âÄýºïÊÓÍøÄ¤·ºÆðÐÂÉúѪ¹ÜÒÔ¼°ÑÛµ×Ѫ¹ÜÓ«¹âÔìÓ°ÊӲ췺ÆðѪ¹ÜÉøÂ© £¬ÎªÀֳɽ¨ÉèÁËCNV¶¯ÎïÄ£×Ó¡£µ«Ïà±ÈÊóÀàºÍ¼ÒÍà £¬·ÇÈËÀàÁ鳤ÀàµÄCNVÉøÂ©ÂʽϵÍÔ¼30£¥ £¬Èý¶ÈËðÉËÔ¼Õ¼70£¥ £¬ËĶÈËðÉËԼΪ20£¥~40£¥¡£ÊµÑé×éӦѡÓÃ8~10Ö»ºï²Å»ª»ñµÃ¾ßÓÐͳ¼ÆÑ§ÒâÒåµÄЧ¹û¡£ÓÉÓÚºïȪԴÉÙ £¬Óöȸß £¬ËÇÑø½ÏÄÑÌâ £¬Ä£×ÓÖÆ×÷Ðè4ÖÜÒÔÉÏ £¬Òò´ËÓ¦ÓÃÊÜÏÞ¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

СÊ󼤹âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊԼΪ80£¥ £¬Íõ魯âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊÔ¼50£¥ £¬¶øÑ¡Ó÷ÇÈËÀàÁ鳤ÀදÎD¹âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊ×îµÍÔ¼30£¥¡£¼¤¹âÓÕµ¼CNV¶¯ÎïÄ£×Ó¿ÉÄ£ÄâÈËÀàʪÐÔAMD¼²²¡ £¬½ÓÄÉÕâÖÖÒªÁìÖ±½ÓËðÉËÂöÂçĤ £¬ÓëÈËÀàCNV±£´æÅäºÏÖ®´¦ £¬¹ØÓÚÑо¿ÊªÐÔAMDµÄ·¢²¡»úÖÆÓëÖÎÁÆÒªÁìÓÐÖ÷ÒªµÄÁÙ´²¼ÛÖµ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÍõÓ¦Àû £¬»ÝÑÓÄ꣮ÌÇÄò²¡ÊÓÍøÄ¤²¡±ä»»ÎïÄ£×ÓÑ¡ÔñµÄ×¢ÖØÊÂÏÖлªÑÛ¿ÆÔÓÖ¾ £¬2012,48 (7):587-590

2.Baehr W, Frederick JM. Naturally occurring animal models with outer retina phenotypes. Vis Res,2009,49: 2636-2652

3.Bourne MC, Campbell DA, Tansley K. Hereditary degeneration of rat retina. Br J Ophthalmol, 1938,22(10): 613-623

4.Bundey S,Crews SJ. A study of retinitis pigrnentosa in the city of Birmingham-I. J Med Genet, 1984,21(6):417-420

5.Chang B, Heckenlively IB,Bayley PR.et a.I. The nob2 mouse, a null mutation in Cacnalf: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci, 2006, 23 (1): 11-24

6.Criswell MH,Ciulla TA,Hill TE,et al. The squirrelmonkey: characterization of a new-world primate model of xperimental choroidal neovascularizalion and comparison with the macaque. Invest Ophthalmol Vis Sci,2004, 45 (2): 625-634

7.Gu Y, Wang L,Zhou J,et al. A naturally-occurring mutation in CacnaIf in a rat model of congenital stationary night blindness. Mo! Vis,2008, 14(1):20-28

8.Lue CL. Rod cell activity in retinal degenerative rats. J Formos Med Assoc, 1994,93(7):605-610

9.Pinkert CA. Transgenic animal technology. New York: Academic Press, 1994

10.Sato H, Suzuki T, Ikeda K, et aL A monogenic dominant mutation in Rom l generated by N-ethyl-N-nitrosourea mutagenesis causes retinal degeneration in mice. Mol Vis,2010, 16:378-391

11.Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci, 1983, 24 (3):285-287

12.Won J, Shi LY, Hicks W, et al. Mouse model resources for vision research. J Ophthalmol,2011,2011:391384

13.Xie B,Nakanishi S,Guo Q,et al. A novel middle­wavelength opsin (M-opsin) null-mutation in the retinal cone dysfunction ral. Exp Eye Res,2010,91(1):26-33

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ÄêËêÏà¹ØÐԻư߱äÐÔ
ÄêËêÏà¹ØÐԻư߱äÐÔ

ǰÑÔ

ÄêËêÏà¹ØÐԻư߱äÐÔ(age related macular dege­neralion, AMD)ÊÇ65ËêÒÔÉÏÍíÄêÈËÖÂäµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ¡£AMD·ÖΪÎÞÐÂÉúѪ¹ÜÌìÉúµÄ¸ÉÐÔÒÔ¼°ÐÂÉúѪ¹ÜÌìÉúµÄʪÐÔÌåÏÖ¡£ÊªÐÔAMD»¼Õß±¬·¢CNVÊǵ¼ÖÂÊÓÁ¦ËðʧµÄ×î³£¼ûÒòËØ¡£±¾Õ½«ÏÈÈÝCNVµÄÔìÄ£ÒªÁì¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó¡¢¼ÒÍá¢â¨ºï

¡¾ÔìÄ£»úÖÆ¡¿£º

¼¤¹âÓÕµ¼CNVÄ£×ÓÊdz£¼ûµÄÒªÁì¡£1979Äê £¬RyanµÈÊ״νÓÄɸ߹¦Âʼ¤¹â´©Í¸BruchĤ֯×÷³öCNV¶¯ÎïÄ£×Ó¡£1989Äê £¬DobiÆ·¼¶Ò»´ÎÓ¦ÓÃ647nm²¨³¤¡¢120mWµÄë´¼¤¹â¿ÉÔì³ÉCNVÄ£×Ó¡£1998Äê £¬TobeµÈ½«ë´¼¤¹â¹âÄýÊõÓ¦ÓÃÓÚÖÆ×÷СÊóCNVÄ£×Ó £¬ÒԺ󼤹âÓÕµ¼CNVÄ£×Ó±»ÆÕ±éÓ¦ÓÃÓÚ»ù´¡ÊµÑéºÍÖÎÁÆÒªÁìµÄÑо¿ÖС£À¶ÂÌë²¼¤¹â´©Í¸Á¦½ÏÈõ £¬Ö÷Òª×÷ÓÃÓÚÊÓÍøÄ¤ÄÚ²ãºÍRPE²ã¡£ë´¼¤¹âÖ÷Òª×÷ÓÃÓÚRPEºÍÂöÂçĤÄڲ㡣¼¤¹âÓÕµ¼CNVÄ£×ÓµÄÓŵãÔÚÓÚÓëÈËÀàCNV¼²²¡±¬·¢×ÔÈ»Àú³ÌÏàËÆ £¬µ«²î±ðÑо¿CNVÄ£×ÓÀÖ³ÉÂʲî±ð £¬Óë²î±ðʵÑé½ÓÄɶ¯ÎïÀàÐÍ¡¢¼¤¹âÖÖÀ༰¶ÔÊÓ²ìÕï¶ÏCNVµÄ±ê×¼·×ÆçÓйØ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

1.СÊó Ë«ÑÛµÎÓø´·½ÍÐßÁ¿¨°·µÎÑÛҺɢͫ £¬¸¹Ç»×¢Éä1£¥Îì°Í±ÈÍ×ÄÆ(10ml/kg)Âé×íСÊó £¬ÊµÑéÑÛµÎÓÃÒ½ÓÃ͸Ã÷ÖÊËáÄÆÄý½º £¬ÑÛǰ°²ÅÅ2cm×2cm¸Ç²£Æ¬ £¬¾­ÁÑ϶µÆÓÃ532nm¼¤¹â¹¦ÂÊ200mW £¬¹â°ßÖ±¾¶100m £¬ÆØ¹âʱ¼ä100ºÁÃë £¬¾àÊÓÈéÍ·1.5-2.0PI×óÓÒλÖÃÒÔÊÓÈéͷΪÖÐÐľÙÐйâÄý £¬ÆäÖÐÐÐCNVÄ£×ÓÅжϺÍÃâÒßÓ«¹âȾɫ×éСÊó¹âÄý4~6µã£¯ÑÛ£»¹âÄýºóÓÐÆøÅݱ¬·¢±ê¼Ç»÷ÆÆBruchĤ £¬ ¼ÇΪÓÐÓõã¡£

2.¼ÒÍà ÍÃÑÛ¼¤¹âÓÕµ¼Ä£×ÓÔÚº£ÄÚÓ¦ÓýÏΪÆÕ±é £¬ÓŵãÔÚÓÚÍÃÑÛ½ÏÖ®ÊóÑÛ´ó £¬Ò×ÓÚÄ£×ÓʵÑé²Ù×÷Óë¼ì²é¡£Ë«ÑÛɢͫ £¬ÑÛ±íµÎÈëÍâòÂé×í¡£Ã¿Ö»ÑÛÔÚÈ«ÊÓÍøÄ¤¾µÏÂÓÃë´¼¤¹â £¬²¨³¤647nm £¬¹¦ÂÊ700~800mW £¬¹â°ßÖ±¾¶50µm £¬¼¤¹â¹¦ÂÊÆØ¹âʱ¼ä0.05Ãë £¬ÔÚÊÓÈéÍ·¼°ËèÏßÏ·½¹âÄý20¸öµã £¬¹â°ß¾àÀë300µm¡£

3.â¨ºï ºïµÄÊÓÍøÄ¤¼°»Æ°ß½á¹¹ÓëÈËÀàÏàËÆ £¬ÑÛÇò¾Þϸ±ãÓÚ²Ù×÷ £¬¾ßÓÐÓ«¹âÉøÂ©µÄÌØµã £¬ÊÇÓÃÓÚÁÙ´²Ò©ÎïɸѡµÄÊ×ѡģ×Ó¡£RyanµÈʹÓÃë²¼¤¹â £¬¹¦ÂÊ200~950mW £¬¹â°ßÖ±¾¶50~200µm £¬ÆØ¹âʱ¼ä0.1~0.5Ãë¡£

¡¾Ä£×ÓÌØµã¡¿£º

1.СÊó ³£½ÓÄÉÃâÒß×黯ÊÖÒÕÓ¦ÓÃCD31±ê¼ÇÄÚÆ¤Ï¸°û £¬ÔÚ¹âÒɺó14ÌìʱCNVÄ£×ÓÊóµÄÊÓÍøÄ¤¹â¼¤²¿Î»¿É¼ûÏÔ×ŵÄÂÌɫӫ¹âÍÅ¿é £¬Åú×¢ÐÂÉúѪ¹ÜÐγÉ £¬´Ó¶øÌåÏÖCNVÄ£×ÓÓÕµ¼Àֳɡ£

2.¼ÒÍà ¼¤¹â°ß·ºÆðǿӫ¹âÉøÂ©ÎªCNVÐγÉ £¬µÚ3~4ÖܼûÎȹ̵ÄÉøÂ©¹â°ß £¬CNV±¬·¢ÂÊ66.7£¥ £¬ÉøÂ©ÂÊ51.7£¥¡£¹âÄýºó3Ìì¼´ÓÐÉÙÁ¿¹â°ß·ºÆðÓ«¹âÉøÓ¿ £¬²¢Öð½¥Ôö¶à £¬21Ìì´ïá¯Áë £¬²¢Ò»Á¬µ½¹âÄýºó56Ìì¡£OCTÏÔʾÔìÄ£ºó7ÌìÉÙÁ¿¹â°ß²¿Î»É«ËØÉÏÆ¤²ã·´ÉäÖÐÖ¹ £¬ÆäÏ·½¾ÖÔîÐÔ¸ßÃܶȺì°×É«·´ÉäÇø³ÊÍÅ¿é×´¡¢ËóÐλò²»¹æÔòÐÎ £¬±ßÑØÎªñ£ºÛÐγɵIJ»¹æÔòÇ¿·´ÉäÇø £¬CNV·ºÆð£»Ö®ºóCNVÖð½¥Ôö¶à £¬ÖÁ21Ìì¸÷×é´ï×î¶à£»ÍíÆÚ²¿·ÖCNVñ£ºÛ»¯¡£Ó«¹âÉøÂ©µÄÅÌËã[£¨Ó«¹âÉøÂ©±¬·¢ÂÊ£½·ºÆðÓ«¹âÉøÂ©µÄ¼¤¹âµãÊý£¯ËùÊÓ²ìµÄ¼¤¹âµãÊý£©×100£¥]¡£

3.ºï ¹âÄýºïÊÓÍøÄ¤·ºÆðÐÂÉúѪ¹ÜÒÔ¼°ÑÛµ×Ѫ¹ÜÓ«¹âÔìÓ°ÊӲ췺ÆðѪ¹ÜÉøÂ© £¬ÎªÀֳɽ¨ÉèÁËCNV¶¯ÎïÄ£×Ó¡£µ«Ïà±ÈÊóÀàºÍ¼ÒÍà £¬·ÇÈËÀàÁ鳤ÀàµÄCNVÉøÂ©ÂʽϵÍÔ¼30£¥ £¬Èý¶ÈËðÉËÔ¼Õ¼70£¥ £¬ËĶÈËðÉËԼΪ20£¥~40£¥¡£ÊµÑé×éӦѡÓÃ8~10Ö»ºï²Å»ª»ñµÃ¾ßÓÐͳ¼ÆÑ§ÒâÒåµÄЧ¹û¡£ÓÉÓÚºïȪԴÉÙ £¬Óöȸß £¬ËÇÑø½ÏÄÑÌâ £¬Ä£×ÓÖÆ×÷Ðè4ÖÜÒÔÉÏ £¬Òò´ËÓ¦ÓÃÊÜÏÞ¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

СÊ󼤹âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊԼΪ80£¥ £¬Íõ魯âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊÔ¼50£¥ £¬¶øÑ¡Ó÷ÇÈËÀàÁ鳤ÀදÎD¹âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊ×îµÍÔ¼30£¥¡£¼¤¹âÓÕµ¼CNV¶¯ÎïÄ£×Ó¿ÉÄ£ÄâÈËÀàʪÐÔAMD¼²²¡ £¬½ÓÄÉÕâÖÖÒªÁìÖ±½ÓËðÉËÂöÂçĤ £¬ÓëÈËÀàCNV±£´æÅäºÏÖ®´¦ £¬¹ØÓÚÑо¿ÊªÐÔAMDµÄ·¢²¡»úÖÆÓëÖÎÁÆÒªÁìÓÐÖ÷ÒªµÄÁÙ´²¼ÛÖµ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÍõÓ¦Àû £¬»ÝÑÓÄ꣮ÌÇÄò²¡ÊÓÍøÄ¤²¡±ä»»ÎïÄ£×ÓÑ¡ÔñµÄ×¢ÖØÊÂÏÖлªÑÛ¿ÆÔÓÖ¾ £¬2012,48 (7):587-590

2.Baehr W, Frederick JM. Naturally occurring animal models with outer retina phenotypes. Vis Res,2009,49: 2636-2652

3.Bourne MC, Campbell DA, Tansley K. Hereditary degeneration of rat retina. Br J Ophthalmol, 1938,22(10): 613-623

4.Bundey S,Crews SJ. A study of retinitis pigrnentosa in the city of Birmingham-I. J Med Genet, 1984,21(6):417-420

5.Chang B, Heckenlively IB,Bayley PR.et a.I. The nob2 mouse, a null mutation in Cacnalf: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci, 2006, 23 (1): 11-24

6.Criswell MH,Ciulla TA,Hill TE,et al. The squirrelmonkey: characterization of a new-world primate model of xperimental choroidal neovascularizalion and comparison with the macaque. Invest Ophthalmol Vis Sci,2004, 45 (2): 625-634

7.Gu Y, Wang L,Zhou J,et al. A naturally-occurring mutation in CacnaIf in a rat model of congenital stationary night blindness. Mo! Vis,2008, 14(1):20-28

8.Lue CL. Rod cell activity in retinal degenerative rats. J Formos Med Assoc, 1994,93(7):605-610

9.Pinkert CA. Transgenic animal technology. New York: Academic Press, 1994

10.Sato H, Suzuki T, Ikeda K, et aL A monogenic dominant mutation in Rom l generated by N-ethyl-N-nitrosourea mutagenesis causes retinal degeneration in mice. Mol Vis,2010, 16:378-391

11.Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci, 1983, 24 (3):285-287

12.Won J, Shi LY, Hicks W, et al. Mouse model resources for vision research. J Ophthalmol,2011,2011:391384

13.Xie B,Nakanishi S,Guo Q,et al. A novel middle­wavelength opsin (M-opsin) null-mutation in the retinal cone dysfunction ral. Exp Eye Res,2010,91(1):26-33

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿